ERGOMED

Ergomed Clinical Research is a global contract research organization (CRO) specializing in oncology, rare disease, and complex clinical trials. With more than 25 years of experience and a team of over 100 medical doctors and PhDs, the company supports sponsors from early development planning through trial execution. Its tailored services are designed to address scientific, operational, and regulatory challenges and help advance the development of therapies.

Ergomed’s offerings span clinical development strategy, trial design, regulatory guidance, study start-up, site selection and management, clinical monitoring, project management, and risk-based quality management. Additional capabilities include clinical safety, medical monitoring, data management, biostatistics, programming, medical writing, and regulatory affairs. The company also provides CTMS and eTMF solutions, medical communications, and quality assurance.

Patient-focused support is a central part of its approach. Through Ergomed CARE™, it works to support patients, investigators, and clinical sites, with a focus on enrollment, engagement, and retention. Ergomed also offers consulting across drug development, including regulatory strategy, real-world evidence, and post-launch insights, and serves trials involving vulnerable populations and other complex therapeutic areas.